Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Omalizumab 150 Mg/ml Sol [Gch] (CDM 1920215) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/1920215/by-state?code_type=CDM
“Omalizumab 150 Mg/ml Sol [Gch] (CDM 1920215) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/1920215/by-state?code_type=CDM. Accessed
June 30, 2026 .
“Omalizumab 150 Mg/ml Sol [Gch] (CDM 1920215) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/1920215/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
1920215 — Omalizumab 150 Mg/ml Sol [Gch]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$2,999
National median
$681 – $3,382
IQR (p25 – p75)
2
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 1920215 (CDM), with interquartile range
State Median p25 p75
VT $3,313 $2,999 $3,382
IL $545 $409 $681